Citations Appearing in 2017

  1. Andersson, B.S., P.F. Thall, B.C. Valdez, D.R. Milton, G. Al-Atrash, J. Chen, . . .and R.E. Champlin. Fludarabine with pharmacokinetically guided IV busulfan is superior to fixed-dose delivery in pretransplant conditioning of AML/MDS patients. Bone Marrow Transplant 52(4): 580-587, 2017.
  2. Ayyar, V.S., D.C. DuBois, R.R. Almon and W.J. Jusko. Mechanistic Multi-Tissue Modeling of GILZ Regulation: Integrating Circadian Gene Expression with Receptor-Mediated Corticosteroid Pharmacodynamics. Journal of Pharmacology and Experimental Therapeutics ePub ahead of print, 2017.
  3. Bensman, T.J., J. Wang, J. Jayne, L. Fukushima, A.P. Rao, D.Z. D’Argenio and P.M. Beringer. Pharmacokinetic-Pharmacodynamic Target Attainment Analyses to Determine Optimal Dosing of Ceftazidime-Avibactam for the Treatment of Acute Pulmonary Exacerbations in Cystic Fibrosis. Antimicrobial Agents and Chemotherapy ePub ahead of Print, 2017.
  4. Bergen, P.J., J.B. Bulitta, C.M.J. Kirkpatrick, K.E. Rogers, M.J. McGregor, S.C. Wallis, . . .and C.B. Landersdorfer. Substantial Impact of Altered Pharmacokinetics in Critically Ill Patients on the Antibacterial Effects of Meropenem Evaluated via the Dynamic Hollow-Fiber Infection Model. Antimicrobial Agents and Chemotherapy 61(5), 2017.
  5. Bulman, Z.P., N.S. Ly, J.R. Lenhard, P.N. Holden, J.B. Bulitta and B.T. Tsuji. Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin. Antimicrobial Agents and Chemotherapy 61(4), 2017.
  6. Butterfield-Cowper, J.M. Effects of i.v. push administration on β-lactam pharmacodynamics. American Journal of Health-System Pharmacy 74(9): 170-175, 2017.
  7. Carreno, J.J., B. Lomaestro, J. Tietjan and T.P. Lodise. Pilot Study of a Bayesian Approach To Estimate Vancomycin Exposure in Obese Patients with Limited Pharmacokinetic Sampling. Antimicrobial Agents and Chemotherapy 61(5), 2017.
  8. Chen, X., D.C. DuBois, R.R. Almon and W.J. Jusko. Characterization and Interspecies Scaling of rhTNF-α Pharmacokinetics with Minimal Physiologically-Based Pharmacokinetic (mPBPK) Models. Drug Metabolism and Disposition ePub ahead of Print, 2017.
  9. Chen, X., D.C. DuBois, R.R. Almon and W.J. Jusko. Interrelationships between Infliximab and rhTNF-α in Plasma using Minimal Physiologically-Based Pharmacokinetic (mPBPK) Models. Drug Metabolism and Disposition ePub ahead of Print, 2017.
  10. Cho, H.E. and H.K. Min. Analysis of fenretinide and its metabolites in human plasma by liquid chromatography–tandem mass spectrometry and its application to clinical pharmacokinetics. Journal of Pharmaceutical and Biomedical Analysis 132: 117-124, 2017.
  11. Choquette, A., E. Troncy, M. Guillot, F. Varin and J.R.E. del Castillo. Pharmacokinetics of Lidocaine Hydrochloride Administered with or without Adrenaline for the Paravertebral Brachial Plexus Block in Dogs. PLOS ONE 12(1): e0169745, 2017.
  12. Dave, R.A., K.E. Follman and M.E. Morris. γ-Hydroxybutyric Acid (GHB) Pharmacokinetics and Pharmacodynamics: Semi-Mechanistic and Physiologically Relevant PK/PD Model. The AAPS Journal ePub ahead of Print, 2017.
  13. Dumond, J.B., J. Chen, M. Cottrell, C.R. Trezza, H.M.A. Prince, C. Sykes, . . .and A. Forrest. Population Pharmacokinetics Modeling of Unbound Efavirenz, Atazanavir, and Ritonavir in HIV-Infected Subjects With Aging Biomarkers. CPT: Pharmacometrics & Systems Pharmacology 6(2): 128-135, 2017.
  14. Dumond, J.B., J.W. Collins, M.L. Cottrell, C.R. Trezza, H.M.A. Prince, C. Sykes, . . .and A. Forrest. p16INK4a, a Senescence Marker, Influences Tenofovir/Emtricitabine Metabolite Disposition in HIV-Infected Subjects. CPT: Pharmacometrics & Systems Pharmacology 6(2): 120-127, 2017.
  15. Gara-Boivin, C., J.R.E. del Castillo, M.E. Dunn and C. Bédard. In vitro effects of dalteparin on thrombin generation in canine plasma. Veterinary Clinical Pathology ePub ahead of Print, 2017.
  16. Glassman, P.M. Physiologically-based modeling to predict the clinical behavior of monoclonal antibodies directed against lymphocyte antigens. mAbs 9(2): 297-306, 2017.
  17. Hall, R.G., J.G. Pasipanodya, C. Meek, R.D. Leff, M. Swancutt and T. Gumbo. Fractal Geometry-Based Decrease in Trimethoprim-Sulfamethoxazole Concentrations in Overweight and Obese People. CPT: Pharmacometrics & Systems Pharmacology 5(12): 674-681, 2017.
  18. Hall, R.G., J.G. Pasipanodya, M.A. Swancutt, C. Meek, R. Leff and T. Gumbo. Supervised Machine-Learning Reveals That Old and Obese People Achieve Low Dapsone Concentrations. CPT: Pharmacometrics & Systems Pharmacology ePub ahead of Print, 2017.
  19. Hope, W.W., L. McEntee, J. Livermore, S. Whalley, A. Johnson, N. Farrington, . . .and J.H. Rex. Pharmacodynamics of the Orotomides against Aspergillus fumigatus: New Opportunities for Treatment of Multidrug-Resistant Fungal Disease. mBio 8(4), 2017.
  20. Hyatt, M.W., N.P. Wiederhold, W.W. Hope and K.E. Stott. PHARMACOKINETICS OF ORALLY ADMINISTERED VORICONAZOLE IN AFRICAN PENGUINS (SPHENISCUS DEMERSUS) AFTER SINGLE AND MULTIPLE DOSES. Journal of Zoo and Wildlife Medicine 48(2): 352-362, 2017.
  21. Jones, R.S., M. Parker and M.E. Morris. Quercetin, Luteolin, Phloretin and Morin are Dietary Flavonoid Inhibitors of Monocarboxylate Transporter 6. Molecular Pharmaceutics ePub ahead of Print, 2017.
  22. Khot, A., J. Tibbitts, D. Rock and D.K. Shah. Development of a Translational Physiologically Based Pharmacokinetic Model for Antibody-Drug Conjugates: a Case Study with T-DM1. The AAPS Journal ePub ahead of Print, 2017.
  23. Li, X., D.C. DuBois, R.R. Almon and W.J. Jusko. Effect of Disease-Related Changes in Plasma Albumin on the Pharmacokinetics of Naproxen in Male and Female Arthritic Rats. Drug Metabolism and Disposition 45(5): 476-483, 2017.
  24. . Modeling Sex Differences in Pharmacokinetics, Pharmacodynamics, and Disease Progression Effects of Naproxen in Rats with Collagen-Induced Arthritis. Drug Metabolism and Disposition 45(5): 484-491, 2017.
  25. Li, X., D.C. DuBois, D. Song, R.R. Almon, W.J. Jusko and X. Chen. Modeling Combined Immunosuppressive and Anti-inflammatory Effects of Dexamethasone and Naproxen in Rats Predicts the Steroid-Sparing Potential of Naproxen. Drug Metabolism and Disposition ePub ahead of Print, 2017.
  26. Li, Z., B.-F. Krippendorff and D.K. Shah. Influence of Molecular size on the clearance of antibody fragments. Pharmaceutical Research ePub ahead of Print, 2017.
  27. Lin, Y.-W., Q. Zhou, Y. Hu, N.J. Onufrak, S. Sun, J. Wang, . . .and J. Li. Pulmonary Pharmacokinetics of Colistin Following Administration of Dry Powder Aerosols in Rats. Antimicrobial Agents and Chemotherapy ePub ahead of print, 2017.
  28. Manchandani, P., J. Zhou, J.T. Babic, K.R. Ledesma, L.D. Truong and V.H. Tam. Role of Renal Drug Exposure in Polymyxin B-Induced Nephrotoxicity. Antimicrobial Agents and Chemotherapy 61(4), 2017.
  29. Martirosov, D.M., M.R. Bidell, M.P. Pai, M.H. Scheetz, S.L. Rosenkranz and T.P. Lodise. Relationship between vancomycin exposure and outcomes among patients with MRSA bloodstream infections with vancomycin Etest® MIC values of 1.5 mg/L: A pilot study. Diagnostic Microbiology and Infectious Disease ePub ahead of Print, 2017.
  30. Methaneethorn, J. Population Pharmacokinetic Analyses of Lithium: A Systematic Review. European Journal of Drug Metabolism and Pharmacokinetics ePub ahead of Print, 2017.
  31. Millisor, V.E., J.K. Roberts, Y. Sun, L. Tang, V.M. Daryani, D. Gregornik, . . .and C.F. Stewart. Derivation of new equations to estimate glomerular filtration rate in pediatric oncology patients. Pediatric Nephrology ePub ahead of Print, 2017.
  32. Mohanan, E., J.C. Panetta, K.M. Lakshmi, E.S. Edison, A. Korula, N.A. Fouzia, . . .and P. Balasubramanian. Population pharmacokinetics of fludarabine in patients with aplastic anemia and Fanconi anemia undergoing allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant ePub ahead of Print, 2017.
  33. Nanavati, C. and D.E. Mager. Sequential Exposure of Bortezomib and Vorinostat is Synergistic in Multiple Myeloma Cells. Pharmaceutical Research 34(3): 668-679, 2017.
  34. Nation, R.L., S.M. Garonzik, V. Thamlikitkul, E.J. Giamarellos-Bourboulis, A. Forrest, D.L. Paterson, . . .and F.P. Silveira. Dosing Guidance for Intravenous Colistin in Critically Ill Patients. Clinical Infectious Diseases 64(5): 565-571, 2017.
  35. Navid, F., V.M. Santana, M. Neel, M.B. McCarville, B.L. Shulkin, J. Wu, . . .and N.C. Daw. A phase II trial evaluating the feasibility of adding bevacizumab to standard osteosarcoma therapy. International Journal of Cancer ePub ahead of Print, 2017.
  36. Pai, M.P., B.A. Derstine, M. Lichty, B.E. Ross, J. Sullivan, G.L. Su and S.C. Wang. Relationships of Vancomycin Pharmacokinetics to Body Size and Composition by Computed Tomography Analysis: A novel “Pharmacomorphomic” approach. Antimicrobial Agents and Chemotherapy ePub ahead of print, 2017.
  37. Pai, M.P., J. Hong and L. Krop. Peak Measurement for Vancomycin AUC Estimation in Obese Adults Improves Precision and Lowers Bias. Antimicrobial Agents and Chemotherapy 61(4), 2017.
  38. . Vancomycin Area under the Curve Estimation in Obese Adults: The peak improves precision and lowers bias. Antimicrobial Agents and Chemotherapy ePub ahead of Print, 2017.
  39. RamÍRez, E., S. Aguirre, P. Patricelli, A. Dell’Elce and E. Formentini (2017). Caracterización y comparación de la actividad antibacteriana intrínseca del suero de búfalo y del suero de bovino, FAVE.
  40. Rodriguez, C.A., M. Agudelo, A.F. Zuluaga and O. Vesga. In vivo pharmacodynamics of piperacillin/tazobactam: implications for antimicrobial efficacy and resistance suppression with innovator and generic products. International Journal of Antimicrobial Agents 49(2): 189-197, 2017.
  41. Serrano-Rodríguez, J.M., M. Gómez-Díez, M. Esgueva, C. Castejón-Riber, A. Mena-Bravo, F. Priego-Capote, . . .and A. Muñoz. Pharmacokinetic/pharmacodynamic modeling of benazepril and benazeprilat after administration of intravenous and oral doses of benazepril in healthy horses. Research in Veterinary Science ePub ahead of Print, 2017.
  42. Singh, A.P. and D.K. Shah. Application of a PK-PD Modeling and Simulation-Based Strategy for Clinical Translation of Antibody-Drug Conjugates: a Case Study with Trastuzumab Emtansine (T-DM1). The AAPS Journal ePub ahead of Print: 1-17, 2017.
  43. Singh, A.P. and D.K. Shah. Measurement and Mathematical Characterization of Cell-Level Pharmacokinetics of Antibody-Drug Conjugates: A Case Study with Trastuzumab-vc-MMAE. Drug Metabolism and Disposition ePub ahead of print, 2017.
  44. Smith, J.A., R.V. Donepudi, P.S. Argoti, A.L. Giezentanner, R. Jain, N. Boring, . . .and K.J. Moise. Exploring the Pharmacokinetic Profile of Remifentanil in Mid-Trimester Gestations Undergoing Fetal Intervention Procedures. Frontiers in Pharmacology 8: 11, 2017.
  45. Smith, N.M. Pharmacodynamics of dose-escalated ‘front-loading’ polymyxin B regimens against polymyxin-resistant mcr-1-harbouring Escherichia coli. Journal of Antimicrobial Chemotherapy ePub ahead of Print, 2017.
  46. Srivastava, S., G. Magombedze, T. Koeuth, C. Sherman, J.G. Pasipanodya, P. Raj, . . .and T. Gumbo. Linezolid dose that maximizes sterilizing effect while minimizing toxicity and resistance emergence for tuberculosis. Antimicrobial Agents and Chemotherapy ePub ahead of Print, 2017.
  47. Tran, T.T., V.H. Tam, B.E. Murray, C.A. Arias and K.V. Singh. Efficacy of Telavancin Alone and in Combination with Ampicillin in a Rat Model of Enterococcus faecalis Endocarditis. Antimicrobial Agents and Chemotherapy ePub ahead of Print, 2017.
  48. van Rijn, S.P., S. Srivastava, M.A. Wessels, D. van Soolingen, J.-W.C. Alffenaar and T. Gumbo. Sterilizing Effect of Ertapenem-Clavulanate in a Hollow-Fiber Model of Tuberculosis and Implications on Clinical Dosing. Antimicrobial Agents and Chemotherapy 61(9), 2017.
  49. Varatharajan, S., A. Abraham, S. Karathedath, S. Ganesan, K.M. Lakshmi, N. Arthur, . . .and P. Balasubramanian. ATP-binding casette transporter expression in acute myeloid leukemia: association with in vitro cytotoxicity and prognostic markers. Pharmacogenomics 18(3): 235-244, 2017.
  50. Weiss, M. Empirical models for fitting of oral concentration time curves with and without an intravenous reference. Journal of Pharmacokinetics and Pharmacodynamics 44(3): 193-201, 2017.
  51. Yu, J., L. Zhu, H. Zheng, X. Gong, H. Jiang, J. Chen, . . .and Z. Liu. Sulfotransferases and Breast Cancer Resistance Protein Determine the Disposition of Calycosin in Vitro and in Vivo. Molecular Pharmaceutics ePub ahead of Print, 2017.
  52. Zhang, Q., L. Zhu, X. Gong, Y. Ruan, J. Yu, H. Jiang, . . .and Z. Liu. Sulfonation Disposition of Acacetin: In Vitro and in Vivo. Journal of Agricultural and Food Chemistry 65(24): 4921-4931, 2017.
  53. Zhang, Y., K. Hu, J.H. Beumer, C.J. Bakkenist and D.Z. D’Argenio. RAD-ADAPT: Software for modelling clonogenic assay data in radiation biology. DNA Repair 52: 24-30, 2017.
  54. Zhou, J., K.R. Ledesma, K.-T. Chang, H. Abodakpi, S. Gao and V.H. Tam. Pharmacokinetics and Pharmacodynamics of Minocycline against Acinetobacter baumannii in a Neutropenic Murine Pneumonia Model. Antimicrobial Agents and Chemotherapy 61(5), 2017.